Site icon Florence Daily News

Tuscany’s COVID-19 cases falls further: where to get the vaccine

FLORENCE, ITALY – Tuscany’s COVID-19 cases falls further anche even the Italian Rt reproduction number has fallen again, according to a draft of the nation’s latest weekly coronavirus monitoring report, dropping to 0.72 from 0.78 last week. All of Italy’s regions have an RT below 1 and can be considered low risk.

The draft of the report said the stress COVID-19 is putting on Italy’s heath services is continuing to ease. It said the proportion of intensive-care places taken up by COVID patients was down to 15%, adding that the proportion was not above the critical threshold of 30% in any region.

Friuli Venezia Giulia, Molise and Sardinia will move from yellow to the lowest COVID-risk white zone on May 31, 2021. On Saturday 29 May and Sunday 30 May in Tuscany there are open days where it is possible to have the first dose of vaccine without a reservation or medical prescription. Here are the places where you can get your dose.

May 29, 2021
Calenzano
– Spazio Comunale: from 8 am to 10 pm
Empoli – Sesa: from 8 am to 7 pm
Fucecchio – Palasport from 8 am to 10 pm
Montecatini – Palaterme from 8 am to 10 pm
San Biagio Pistoia- Circolo MCL from 8 am to 10 pm 
Reggello – Palazzetto dello Sport from 8 am to 6 pm

May 30, 2021
Calenzano
– Spazio Comunale: from 8 am to 10 pm
Empoli – Sesa from 8 am to 7 pm
Montecatini – Palaterme from 8 am to 10 pm
Prato – Sala Pellegrinaio Nuovo: from 8 am to 7 pm
Reggello – Palazzetto dello Sport – from 8 am to 6 pm

Since June 3 will be possible for all people aged 16 and over to be vaccinated in Italy, without having to respect age-range criteria, according to a circular letter set to be released on Friday by COVID-19 Emergency Commissioner Francesco Figliuolo.

Up to now, Italy’s vaccination campaign has operated on the basis of a person’s age, with older people and people considered vulnerable because of their medical conditions given priority. The vaccination campaign will be extended to 12-to-15-year-olds soon too, with the European Medicines Agency (EMA) expected to approve jabs for younger adolescents in these days.

Exit mobile version